Whan In Pharm Co.,Ltd. (016580.KS)
KRW 11470.0
(0.61%)
KRW 11470.0
(0.61%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 230.39 Billion | 198.93 Billion | 177.77 Billion | 171.7 Billion | 159.17 Billion | 154.66 Billion |
| Cost of Revenue | 132.26 Billion | 100.14 Billion | 84.28 Billion | 85.1 Billion | 79.99 Billion | 75.36 Billion |
| Gross Profit | 98.12 Billion | 98.79 Billion | 93.49 Billion | 86.6 Billion | 79.18 Billion | 79.3 Billion |
| Operating Expenses | 66.41 Billion | 68.98 Billion | 62.21 Billion | 58.18 Billion | 53.01 Billion | 51.95 Billion |
| Selling, General and Administrative Expenses | 65.34 Billion | 35.29 Billion | 29.07 Billion | 25.57 Billion | 23.56 Billion | 24.36 Billion |
| Research and Development Expenses | 1.07 Billion | 3.33 Billion | 2.65 Billion | 3.31 Billion | 993.27 Million | 647.76 Million |
| Other Expenses | - | 30.36 Billion | 30.47 Billion | 29.29 Billion | 28.45 Billion | -238.81 Million |
| Cost and Expenses | 197.86 Billion | 169.12 Billion | 146.49 Billion | 143.28 Billion | 133.01 Billion | 127.32 Billion |
| Operating Income | 32.52 Billion | 29.81 Billion | 31.27 Billion | 28.41 Billion | 26.16 Billion | 27.34 Billion |
| Interest Expense | 22.65 Million | 51.87 Million | 51.55 Million | 31.41 Million | 20.27 Million | - |
| Income Tax Expense | 4.01 Billion | 6.07 Billion | 7.42 Billion | 7.89 Billion | 9.61 Billion | 7.8 Billion |
| Earnings before Tax | 34.79 Billion | 29.8 Billion | 33.88 Billion | 31.08 Billion | 28.22 Billion | 29.32 Billion |
| Net Income | 29.77 Billion | 23.92 Billion | 26.65 Billion | 23.38 Billion | 18.69 Billion | 21.51 Billion |
| Earnings Per Share Basic | 1950.00 | 1566.86 | 1746.22 | 1531.91 | 1224.59 | 1409.44 |
| Earnings Per Share Diluted | 1950.23 | 1566.86 | 1746.22 | 1531.91 | 1224.59 | 1409.00 |
| Weighted Average Shares Outstanding | 15.26 Million | 15.26 Million | 15.26 Million | 15.26 Million | 15.26 Million | 15.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 15.26 Million | 15.26 Million | 15.26 Million | 15.26 Million | 15.26 Million | 15.27 Million |
| Gross Margin | 0.43 | 0.50 | 0.53 | 0.50 | 0.50 | 0.51 |
| EBIT Margin | 0.16 | 0.19 | 0.21 | 0.20 | 0.20 | 0.19 |
| Profit Margin | 0.13 | 0.12 | 0.15 | 0.14 | 0.12 | 0.14 |
| EBITDA | 36.81 Billion | 34.67 Billion | 38.02 Billion | 32.48 Billion | 32.14 Billion | 31.98 Billion |
| Earnings Before Tax Margin | 0.14 | 0.15 | 0.18 | 0.17 | 0.16 | 0.18 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 68.11 Billion | 63.61 Billion | 61.61 Billion | 58.38 Billion | 230.39 Billion | 58.84 Billion |
| Cost of Revenue | - | 39.2 Billion | 37.13 Billion | 34.83 Billion | 132.26 Billion | 33.21 Billion |
| Gross Profit | 68.11 Billion | 24.41 Billion | 24.47 Billion | 23.55 Billion | 98.12 Billion | 25.62 Billion |
| Operating Expenses | 62.82 Billion | 17.44 Billion | 16.15 Billion | 17.1 Billion | 67.95 Billion | 17.84 Billion |
| Selling, General and Administrative Expenses | - | 16.81 Billion | 11.88 Billion | 16.69 Billion | - | 9.43 Billion |
| Research and Development Expenses | - | 116.13 Million | 4.02 Billion | 126.53 Million | - | 250.22 Million |
| Other Expenses | -62.82 Billion | -506.4 Million | -248.75 Million | -283.3 Million | -1.31 Billion | 468.07 Million |
| Cost and Expenses | 62.82 Billion | 56.64 Billion | 53.29 Billion | 51.93 Billion | 200.22 Billion | 51.05 Billion |
| Operating Income | 5.28 Billion | 6.97 Billion | 8.31 Billion | 6.45 Billion | 30.17 Billion | 7.78 Billion |
| Interest Expense | - | - | 5.34 Million | 5.08 Million | 22.65 Million | 4.71 Million |
| Income Tax Expense | 998 Million | 1.48 Billion | 2.05 Billion | -333.19 Million | 4.01 Billion | 1.75 Billion |
| Earnings before Tax | 5.51 Billion | 7.64 Billion | 9.88 Billion | 7.25 Billion | 34.79 Billion | 8.09 Billion |
| Net Income | 4.51 Billion | 6.2 Billion | 9.07 Billion | 7.56 Billion | 29.77 Billion | 6.34 Billion |
| Earnings Per Share Basic | 242.79 | 406.69 | 594.17 | 495.65 | - | 415.51 |
| Earnings Per Share Diluted | 242.79 | 406.69 | 594.17 | 495.65 | - | 415.51 |
| Weighted Average Shares Outstanding | 18.6 Million | 15.26 Million | 15.26 Million | 15.26 Million | 15.26 Million | 15.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 18.6 Million | 15.26 Million | 15.26 Million | 15.26 Million | 15.26 Million | 15.26 Million |
| Gross Margin | 1.00 | 0.38 | 0.40 | 0.40 | 0.43 | 0.44 |
| EBIT Margin | 0.08 | 0.14 | 0.16 | 0.14 | - | 0.17 |
| Profit Margin | 0.07 | 0.10 | 0.15 | 0.13 | 0.13 | 0.11 |
| EBITDA | 5.28 Billion | 8.92 Billion | 10.14 Billion | 8.22 Billion | - | 9.73 Billion |
| Earnings Before Tax Margin | 0.08 | 0.11 | 0.14 | 0.11 | 0.13 | 0.13 |
RELI
1681
000631
000531
DOHOME
0GN6